June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Controlled vancomycin release from a biodegradable hydrogel ocular drug delivery system
Author Affiliations & Notes
  • Emily Dosmar
    Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
  • William F Mieler
    2Department of Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL
  • Jennifer J Kang Mieler
    Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
  • Footnotes
    Commercial Relationships Emily Dosmar, None; William Mieler, Genentic (C), Thrombogenics (C); Jennifer Kang Mieler, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4145. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emily Dosmar, William F Mieler, Jennifer J Kang Mieler; Controlled vancomycin release from a biodegradable hydrogel ocular drug delivery system. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4145.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: The purpose of this study was to investigate the use of a biodegradable hydrogel to deliver prophylactic vancomycin (VAN) for two weeks following ocular surgery.

Methods: VAN was encapsulated in hydrolytically degradable poly(ethylene glycol)-co-(L-lactic acid) diacrylate (PEG-PLLA-DA) and poly(ethylene glycol) diacrylate (PEG-DA) hydrogels. Polymer concentration, polymer PEG-PLLA-DA:PEG-DA ratio, PEG-DA molecular weight (575 MW or 700 MW), and polymerization time were varied to assess the degradation rate and time of hydrogel. Polymer composition was varied to determine swelling ratios. The mesh size of the hydrogel network was estimated using the Flory-Rehner equations. VAN release profiles were conducted at 37°C; at predetermined intervals, samples were analyzed via high-performance liquid chromatography to quantify VAN concentration.

Results: Hydrogel swelling ratios decreased significantly with increased PEG-DA concentrations (p=7×10-4), demonstrating the dependency of hydrogel swelling ratio on polymer concentration. Hydrogel mesh size estimations ranged from 6.79-7.76 nm regardless of investigated polymer composition. Hydrogels degraded slower as polymer concentration increased and hydrogels with a higher degradable to non-degradable polymer ratio showed a faster overall degradation time. Hydrogels with the same polymer ratio degraded more quickly with lower PEG-DA molecular weight: hydrogels rendered with PEG-DA 575MW degraded 5 days faster than those with 700MW. Hydrogels composed of 20:0 PEG-PLLA-DA:PEG-DA exhibited ~30% cumulative release (of theoretically encapsulated VAN) after 24 hours, 40% release by 1 week, and degraded completely in 9 days. Hydrogels with 17:3 PEG-PLLA-DA:PEG-DA showed ~30% release at 24 hours, 33% at 1 week and degraded completely in 16 days.

Conclusions: This study demonstrated that by modifying polymer concentration and ratio, the degradation and release time of VAN can be controlled. Biodegradable hydrogels may have promise for application as prophylactic antibiotic ocular drug delivery devices.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.